PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 160 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2014. The put-call ratio across all filers is 0.47 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $1,364,000 | +177.8% | 17,766 | +48.8% | 0.38% | +308.5% |
| Q3 2015 | $491,000 | -57.2% | 11,938 | -26.4% | 0.09% | -13.0% |
| Q2 2015 | $1,148,000 | -35.7% | 16,227 | -19.2% | 0.11% | -36.1% |
| Q1 2015 | $1,785,000 | -36.9% | 20,085 | -37.0% | 0.17% | -37.6% |
| Q4 2014 | $2,827,000 | -14.4% | 31,883 | -6.5% | 0.27% | -20.5% |
| Q3 2014 | $3,304,000 | -24.5% | 34,090 | -28.5% | 0.34% | -9.3% |
| Q2 2014 | $4,378,000 | +18.6% | 47,657 | -9.7% | 0.38% | +24.9% |
| Q1 2014 | $3,692,000 | -32.6% | 52,757 | -44.6% | 0.30% | -33.0% |
| Q4 2013 | $5,475,000 | -65.6% | 95,241 | -71.2% | 0.45% | -69.7% |
| Q3 2013 | $15,894,000 | -28.0% | 330,611 | -56.6% | 1.48% | -34.2% |
| Q2 2013 | $22,090,000 | – | 761,709 | – | 2.25% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 360,000 | $21,845,000 | 6.19% |
| Gagnon Advisors, LLC | 213,217 | $12,938,000 | 4.92% |
| GAGNON SECURITIES LLC | 499,333 | $30,300,000 | 4.30% |
| Spyglass Capital Management LLC | 2,117,673 | $128,500,000 | 2.86% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 646,530 | $39,231,000 | 2.30% |
| Paulson & Co. | 1,273,161 | $77,255,000 | 1.85% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 212,112 | $12,871,000 | 1.44% |
| Tygh Capital Management, Inc. | 152,332 | $9,244,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,147,000 | $69,600,000 | 1.24% |
| Rock Springs Capital Management LP | 1,025,000 | $62,197,000 | 1.23% |